ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 177 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $65,000 | +44.4% | 1,145 | +16.2% | 0.00% | – |
Q3 2020 | $45,000 | -23.7% | 985 | -16.9% | 0.00% | – |
Q2 2020 | $59,000 | +15.7% | 1,186 | +17.4% | 0.00% | – |
Q1 2020 | $51,000 | +10.9% | 1,010 | +34.7% | 0.00% | – |
Q4 2019 | $46,000 | +360.0% | 750 | +314.4% | 0.00% | – |
Q3 2019 | $10,000 | -99.4% | 181 | -99.1% | 0.00% | -100.0% |
Q1 2018 | $1,541,000 | +117.7% | 19,058 | +57.9% | 0.00% | +200.0% |
Q4 2017 | $708,000 | -85.1% | 12,068 | -87.1% | 0.00% | -90.0% |
Q4 2014 | $4,765,000 | +2056.1% | 93,715 | +1575.0% | 0.01% | – |
Q3 2014 | $221,000 | – | 5,595 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |